LEGN
Price
$27.73
Change
+$1.04 (+3.90%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
4.96B
105 days until earnings call
Intraday BUY SELL Signals
RGNX
Price
$12.89
Change
+$0.68 (+5.57%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
638.36M
90 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LEGN vs RGNX

Header iconLEGN vs RGNX Comparison
Open Charts LEGN vs RGNXBanner chart's image
Legend Biotech
Price$27.73
Change+$1.04 (+3.90%)
Volume$12.34K
Capitalization4.96B
REGENXBIO
Price$12.89
Change+$0.68 (+5.57%)
Volume$5.34K
Capitalization638.36M
LEGN vs RGNX Comparison Chart in %
View a ticker or compare two or three
VS
LEGN vs. RGNX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEGN is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (LEGN: $26.69 vs. RGNX: $12.21)
Brand notoriety: LEGN and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LEGN: 59% vs. RGNX: 34%
Market capitalization -- LEGN: $4.96B vs. RGNX: $638.36M
LEGN [@Biotechnology] is valued at $4.96B. RGNX’s [@Biotechnology] market capitalization is $638.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LEGN’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • LEGN’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than LEGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LEGN’s TA Score shows that 3 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • LEGN’s TA Score: 3 bullish, 4 bearish.
  • RGNX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both LEGN and RGNX are a bad buy in the short-term.

Price Growth

LEGN (@Biotechnology) experienced а -5.30% price change this week, while RGNX (@Biotechnology) price change was -9.22% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

LEGN is expected to report earnings on Mar 18, 2026.

RGNX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LEGN($4.96B) has a higher market cap than RGNX($638M). RGNX YTD gains are higher at: 57.956 vs. LEGN (-17.963). RGNX has higher annual earnings (EBITDA): -129.93M vs. LEGN (-260.04M). LEGN has more cash in the bank: 968M vs. RGNX (323M). RGNX has less debt than LEGN: RGNX (77.7M) vs LEGN (388M). LEGN has higher revenues than RGNX: LEGN (797M) vs RGNX (156M).
LEGNRGNXLEGN / RGNX
Capitalization4.96B638M777%
EBITDA-260.04M-129.93M200%
Gain YTD-17.96357.956-31%
P/E RatioN/AN/A-
Revenue797M156M511%
Total Cash968M323M300%
Total Debt388M77.7M499%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
18
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LEGNRGNX
RSI
ODDS (%)
Bullish Trend 6 days ago
70%
Bearish Trend 6 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 6 days ago
75%
Bearish Trend 6 days ago
87%
Momentum
ODDS (%)
Bearish Trend 6 days ago
80%
Bullish Trend 6 days ago
78%
MACD
ODDS (%)
Bearish Trend 6 days ago
83%
Bullish Trend 6 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
84%
Bullish Trend 6 days ago
76%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
77%
Declines
ODDS (%)
Bearish Trend 14 days ago
80%
Bearish Trend 14 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
76%
Bearish Trend 6 days ago
90%
Aroon
ODDS (%)
Bearish Trend 6 days ago
89%
Bearish Trend 6 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
LEGN
Daily Signal:
Gain/Loss:
RGNX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LZISX10.44N/A
N/A
Lazard Global Small Cap Eq Instl
DCCAX30.57N/A
N/A
Nomura Small Cap Core A
MMGEX10.12N/A
N/A
MassMutual Small Cap Gr Eq A
ETAHX51.30N/A
N/A
Eventide Healthcare & Life Sciences A
SLPAX15.04N/A
N/A
SEI Small Cap A (SIIT)

LEGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LEGN has been loosely correlated with CLDX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LEGN jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEGN
1D Price
Change %
LEGN100%
-0.54%
CLDX - LEGN
39%
Loosely correlated
+2.85%
CRSP - LEGN
38%
Loosely correlated
-1.13%
BEAM - LEGN
38%
Loosely correlated
-2.83%
RGNX - LEGN
38%
Loosely correlated
-3.10%
IOVA - LEGN
37%
Loosely correlated
-4.48%
More

RGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with SYRE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
-3.10%
SYRE - RGNX
58%
Loosely correlated
-0.91%
BEAM - RGNX
55%
Loosely correlated
-2.83%
DNLI - RGNX
55%
Loosely correlated
-1.71%
VYGR - RGNX
55%
Loosely correlated
-4.89%
RXRX - RGNX
54%
Loosely correlated
-0.69%
More